Splenic abscess secondary to COVID-19 acute infection: A case report and literature review

• Published in: Medicine (Baltimore) Vol. 103; no. 31; p. e39194
• Main Authors: Wang, Wei, Zhai, Wen-Hui, Zhang, Ying, Tao, Li, Li, Yun, Jiang, Tong-Xue, Zhang, Jin-Ping
• Format: Journal Article
• Language: English
• Published: United States Lippincott Williams & Wilkins 02.08.2024
• Subjects: Abscess - etiology; Aged; Clinical Case Report; COVID-19 - complications; COVID-19 - diagnosis; Female; Humans; Meropenem - therapeutic use; SARS-CoV-2; Splenic Diseases - etiology; Tomography, X-Ray Computed
• ISSN: 0025-7974; 1536-5964; 1536-5964
• DOI: 10.1097/MD.0000000000039194

Splenic abscess is relatively rare in clinical practice as an invasive disease. However, during the continuous prevalence of coronavirus disease 2019 (COVID-19), the incidence rate of splenic abscess showed an upward trend. However, because the etiology of splenic abscess is not specific, it is easy to be covered by the respiratory symptoms of COVID-19, resulting in omission or delay in diagnosis. If splenic abscesses cannot be treated in a timely manner, the mortality rate can reach 100%. Therefore, it is important to fully understand the correlation between COVID-19 and the development of splenic abscesses. A female patient, 71 years of age, was admitted to our hospital because of cough and sputum for 1 week and fever for 2 days. According to the positive results of novel coronavirus nucleic acid and chest computed tomography, novel coronavirus pneumonia was diagnosed. On the 4th day after treatment, abdominal distension and vomiting were observed. Abdominal ultrasound indicated splenomegaly and mixed echo masses in the spleen and abdominal computed tomography indicated 2 new round low-density lesions were found in the spleen. The patient was diagnosed with secondary splenic abscess after COVID-19 infection. The patient and her family members refused to undergo ultrasound-guided splenic puncture drainage and splenectomy. In terms of treatment, she was given meropenem combined with vancomycin to continue anti-infection treatment. The patient's body temperature and infection indicators gradually increased, and the scope of splenic abscess continued to expand. The infection worsened and progressed to septic shock. The patient abandoned rescue drugs and invasive treatment, and died on the 9th day after admission. This case introduces the clinical characteristics of secondary splenic abscess caused by COVID-19 from the aspects of etiology, disease course, clinical manifestations, auxiliary examinations, and treatment methods. The focus is on improving the understanding of clinical doctors about secondary splenic abscesses caused by COVID-19, providing reference for early diagnosis and timely treatment.